Antimicrobials, mucosal coating agents, anesthetics, analgesics, and nutritional supplements for alimentary tract mucositis

被引：43

作者：

Barasch, Andrei

Elad, Sharon

Altman, Arnold

Damato, Kathryn

Epstein, Joel

机构：

[1] Univ Illinois, Dept Oral Med & Diagnost Sci MC 838, Chicago, IL 60612 USA

[2] Univ Connecticut, Farmington, CT USA

[3] Univ Alabama Birmingham, Sch Dent, Dept Diagnost Sci, Birmingham, AL 35294 USA

[4] Hebrew Univ Jerusalem Hadassah Hosp & Med Sch, Sch Dent Med, Dept Oral Med, IL-91120 Jerusalem, Israel

[5] Childhood Canc Univ Connecticut, Ctr Hlth, Farmington, CT USA

[6] Hematol Oncol Connecticut Childrens Med Ctr, Farmington, CT USA

来源：

SUPPORTIVE CARE IN CANCER | 2006年 / 14卷 / 06期

关键词：

mucositis; antimicrobials; coating agents; anesthetics; analgesics; nutritional supplement;

D O I：

10.1007/s00520-006-0066-1

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

This review focuses on the value of several groups of agents for the prevention and treatment of mucositis. The review refers to alimentary mucositis as a generalized term that includes oral mucositis and gastrointestinal mucositis. This paper is part of the systematic review made by the mucositis study group which operates in the Multinational Association of Supportive Care in Cancer (MASCC)/International Society of Oral Oncology (ISOO). Several new guidelines are suggested in this review as an update to the primary systematic review that was published by the same group in 2004.

引用

收藏

页码：528 / 532

页数：5

相关论文

共 25 条

[1] Prophylaxis with povidone-iodine against induction of oral mucositis by radiochemotherapy [J].

Adamietz, IA ;

Rahn, R ;

Bottcher, HD ;

Schafer, V ;

Reimer, K ;

Fleischer, W .

SUPPORTIVE CARE IN CANCER, 1998, 6 (04) :373-377

[2] Risk factors for ulcerative oral mucositis in cancer patients: unanswered questions [J].

Barasch, A ;

Peterson, DE .

ORAL ONCOLOGY, 2003, 39 (02) :91-100

[3] A prospective randomized trial comparing cyclosporine and short course methotrexate with cyclosporine and mycophenolate mofetil for GVHD prophylaxis in myeloablative allogeneic bone marrow transplantation [J].

Bolwell, B ;

Sobecks, R ;

Pohlman, B ;

Andresen, S ;

Rybicki, L ;

Kuczkowski, E ;

Kalaycio, M .

BONE MARROW TRANSPLANTATION, 2004, 34 (07) :621-625

[4] Effect of topical morphine for mucositis-associated pain following concomitant chemoradiotherapy for head and neck carcinoma [J].

Cerchietti, LCA ;

Navigante, AH ;

Bonomi, MR ;

Zaderajko, MA ;

Menéndez, PR ;

Pogany, CE ;

Roth, BMC .

CANCER, 2002, 95 (10) :2230-2236

[5] Prevention of oral mucositis in paediatric patients treated with chemotherapy: a randomised crossover trial comparing two protocols of oral care [J].

Cheng, KKF ;

Chang, AM ;

Yuen, MP .

EUROPEAN JOURNAL OF CANCER, 2004, 40 (08) :1208-1216

[6]

Costa Edja Maria Melo de Brito, 2003, Pesqui Odontol Bras, V17, P147, DOI 10.1590/S1517-74912003000200009

[7] Sirolimus and tacrolimus without methotrexate as graft-versus-host disease prophylaxis after matched related donor peripheral blood stem cell transplantation [J].

Cutler, C ;

Kim, HT ;

Hochberg, E ;

Ho, V ;

Alyea, E ;

Lee, SJ ;

Fisher, DC ;

Miklos, D ;

Levin, J ;

Sonis, S ;

Soiffer, RJ ;

Antin, JH .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (05) :328-336

[8] Transdermal fentanyl in HSCT patients: an open trial using transdermal fentanyl for the treatment of oral mucositis pain [J].

Demarosi, F ;

Lodi, G ;

Soligo, D ;

Sardella, A ;

Della Volpe, A ;

Carrassi, A ;

Deliliers, GL .

BONE MARROW TRANSPLANTATION, 2004, 33 (12) :1247-1251

[9] Radiation-induced mucositis: A randomized clinical trial of micronized sucralfate versus salt & soda mouthwashes [J].

Dodd, MJ ;

Miaskowski, C ;

Greenspan, D ;

MacPhail, L ;

Shih, AS ;

Shiba, G ;

Facione, N ;

Paul, SM .

CANCER INVESTIGATION, 2003, 21 (01) :21-33

[10]

Drake Ross, 2004, J Palliat Med, V7, P419, DOI 10.1089/1096621041349590